Zobrazeno 1 - 10
of 30
pro vyhledávání: '"David P. Durham"'
Autor:
Aleisha R. Brock, Joshua V. Ross, Scott Greenhalgh, David P. Durham, Alison Galvani, Sunil Parikh, Adrian Esterman
Publikováno v:
Infectious Disease Modelling, Vol 2, Iss 2, Pp 161-187 (2017)
Background: The use of poor quality antimalarial medicines, including the use of non-recommended medicines for treatment such as sulfadoxine-pyrimethamine (SP) monotherapy, undermines malaria control and elimination efforts. Furthermore, the use of s
Externí odkaz:
https://doaj.org/article/27e97cf7a2fd4ad68c117220894cb065
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 4, Pp 608-616 (2016)
To quantify the effect of hospital and community-based transmission and control measures on Clostridium difficile infection (CDI), we constructed a transmission model within and between hospital, community, and long-term care-facility settings. By pa
Externí odkaz:
https://doaj.org/article/623ecc219805486696f6df9f2aca122e
Autor:
Jason Asher, Annabelle Lemenuel-Diot, Matthew Clay, David P. Durham, Luis Mier-y-Teran-Romero, Carlos J. Arguello, Sebastien Jolivet, Diana Y. Wong, Klaus Kuhlbusch, Barry Clinch, Jean-Eric Charoin
Publikováno v:
PLoS computational biology. 19(1)
To aid understanding of the effect of antiviral treatment on population-level influenza transmission, we used a novel pharmacokinetic–viral kinetic transmission model to test the correlation between nasal viral load and infectiousness, and to evalu
Autor:
Mary B. Williams, Alison P. Galvani, David Gahn, Douglas A. Drevets, Hélène Carabin, Jan Fox, John W. Ward, Crystal David, Whitney Essex, Anna Miller, Kaitlin M. McGrew, Stephen Jones, Tara Ritter, David P. Durham, Jorge Mera, Sally Bouse, Lindsay Boeckman
Publikováno v:
JAMA Network Open
This cohort study evaluates the first 22 months of implementation of the Cherokee Nation Heath Services community-based program designed to eliminate hepatitis C virus (HCV) infection.
Key Points Question Can a community-based tribal hepatitis C
Key Points Question Can a community-based tribal hepatitis C
Publikováno v:
International Journal of Radiation Biology. 96:4-11
Purpose: In the wake of a nuclear detonation, individuals with acute radiation syndrome will be a significant source of morbidity and mortality. Mathematical modeling can compare response strategie...
Autor:
Youfang Cao, Chad R. Wells, Aftab A. Ansari, Siddappa N. Byrareddy, David P. Durham, Alison P. Galvani, Jeffrey P. Townsend, Alan S. Perelson, Nancy H. Ruddle
Publikováno v:
PLoS Computational Biology, Vol 17, Iss 6, p e1009031 (2021)
PLoS Computational Biology
PLoS Computational Biology
Treating macaques with an anti-α4β7 antibody under the umbrella of combination antiretroviral therapy (cART) during early SIV infection can lead to viral remission, with viral loads maintained at < 50 SIV RNA copies/ml after removal of all treatmen
Autor:
Hilary Flumo, Mosoka Fallah, Caroline J Crystal, David P. Durham, Laura Skrip, Tolbert G. Nyenswah, Alison P. Galvani
Publikováno v:
Global Maternal and Child Health ISBN: 9783319976365
In addition to physical ailments and the possibility of viral persistence in reproductive organs, female Ebola survivors face significant stigma and associated psychological health issues. Programs to meet the varied reproductive health needs of fema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f60091d1bcd2b810213c0bd42e1adef5
https://doi.org/10.1007/978-3-319-97637-2_9
https://doi.org/10.1007/978-3-319-97637-2_9
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 4, Pp 608-616 (2016)
Emerging Infectious Diseases
Emerging Infectious Diseases
Empirical quantification of transmission dynamics for all settings is needed when evaluating interventions and control strategies.
To quantify the effect of hospital and community-based transmission and control measures on Clostridium difficile
To quantify the effect of hospital and community-based transmission and control measures on Clostridium difficile
Publikováno v:
The Lancet. 390:2012-2014
Autor:
Philip A. Chan, Alyson L. Singleton, Maximilian R F King, David P. Durham, Jeffrey P. Townsend, Alison P. Galvani, William C. Goedel, Brandon D.L. Marshall
Summary Background Oral pre-exposure prophylaxis (PrEP) prevents HIV infection in men who have sex with men (MSM); however, adherence is an ongoing concern. Long-acting injectable PrEP is being tested in phase 3 trials and could address challenges as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::037de895d91bde107d6da1f44e99c081
https://europepmc.org/articles/PMC6138558/
https://europepmc.org/articles/PMC6138558/